Work

Economic Outcomes Associated with Switching Individuals with Schizophrenia Between Risperidone and Olanzapine

Year: 2004

Type: article

Study design: Observational Study

Source: CNS Drugs

DOI: 10.2165/00023210-200418030-00002

Authors: Zhongyun Zhao, Madhav Namjoshi, Beth L Barber, Danielle L Loosbrock, Sandra L Tunis, Baojin Zhu, Alan Breier

Institution: Eli Lilly (United States)

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1020323627

FWCI: 0.622

Cites: 29

Cited by: 10

Related to: 10